Expression of EBNA-1 mRNA is regulated by cell cycle during Epstein- Barr virus type I latency

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3154-3161

  Davenport, Matthew G ^a   Pagano, Joseph S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOHEXIMIDE; LUCIFERASE; NOCODAZOLE; NUCLEAR PROTEIN; VIRUS RNA;

ARTICLE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL SYNCHRONIZATION; EPSTEIN BARR VIRUS; GENE EXPRESSION; GENE LOCUS; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MITOSIS INHIBITION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS INHIBITION; REGULATORY MECHANISM; VIRUS GENOME; VIRUS INFECTION; VIRUS REACTIVATION;

EID: 0033015741     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3154-3161.1999     Document Type: Article

References (72)

1. Adams, A. 1987. Replication of Epstein-Barr virus genomes in Raji cells. J. Virol. 61:1743-1746.
2. Adams, P. D., and W. G. Kaelin. 1995. Transcriptional control by E2F. Semin. Cancer Biol. 6:99-108.
3. Alfieri, C., M. Birkenbach, and E. Kieff. 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608.
4. Ambinder, R. F., W. A. Shah, D. A. Rawlins, G. S. Hayward, and S. D. Hayward. 1990. Definition of the sequence requirements for binding of the EBNA-1 protein to its palindromic target sites in Epstein-Barr virus DNA. J. Virol. 64:2369-2379.
5. Ben-Bassat, H., N. Goldblum, S. Mitrani, T. Goldblum, J. M. Yoffey, M. M. Cohen, Z. Bentwitch, B. Ramot, E. Klein, and G, Klein. 1977. Establishment in culture of a new type of lymphocyte from a "Burkitt-like" lymphoma (line D.G.-75). Int. J. Cancer 19:27-33.
6. Bennett, J. D., P. Farlie, and R. J. Watson. 1996. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts. Oncogene 13:1073-1082.
7. Bjorklund, S., S. Skog, B. Tribukait, and L. Thelander. 1990. S-phase-specific expression of mammalian ribonucleotide reductase R1 and R2 subunit mRNAs. Biochemistry 29:5452-5458.
8. Cartwright, P., H. Muller, C. Wagener, K. Holm, and K. Helin. 1998. E2F-6: a novel member of the E2F family is an inhibitor of E2F-dependent transcription. Oncogene 17:611-623.
9. Chen, F., J.-Z. Zou, L. DiRenzo, G. Winberg, L.-F. Hu, E. Klein, G. Klein, and I. Ernberg. 1995. A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP-1. J. Virol. 69:3752-3758.
10. Chen, M.-R., J. M. Middeldorp, and S. D. Hayward. 1993. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67:4875-4885.
11. Cobrinik, D. 1996. Regulatory interaction among E2Fs and cell cycle control proteins. Curr. Top. Microbiol. Immunol. 208:31-61.
12. 1/S-regulatory genes. Mol. Cell. Biol. 15:4215-4224.
13. Dulic, V., E. Lees, and S. I. Reed. 1992. Association of human cyclin A with a periodic G1-S phase protein kinase. Science 257:1958-1961.
14. Engstrom, Y., S. Eriksson, I. Jildevik, S. Skog, L. Thelander, and B. Tribukait. 1985. Cell cycle-dependent expression of mammalian ribonucleotide reductase. J. Biol. Chem. 260:9114-9116.
15. Eriksson, S., A. Grasland, S. Skog, L. Thelander, and B. Tribukait. 1984. Cell cycle dependent expression of mammalian ribonucleotide reductase. The S phase correlated increase in subunit M2 is regulated by de novo protein synthesis. J. Biol. Chem. 259:11695-11700.
16. Gaubatz, S., J. G. Wood, and D. M. Livingston. 1998. Unusual proliferation arrest and transcriptional control properties of a newly discovered E2F family member, E2F-6. Proc. Natl. Acad. Sci. USA 95:9190-9195.
17. Geng, Y., E. N. Eaton, M. Picon, J. M. Roberts, A. S. Lundberg, A. Gifford, C. Sardet, and R. A. Weinberg. 1996. Regulation of cyclin E transcription by E2Fs and retinoblastoma protein. Oncogene 12:1173-1180.
18. Girard, F., U. Strausfeld, A. Fernandez, and N. J. C. Lamb. 1991. Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67:1169-1179.
19. Gulley, M. L., M. Raphael, C. T. Lutz, D. W. Ross, and N. Raab-Traub. 1992. Epstein-Barr virus integration in human lymphomas and lymphoid cell lines. Cancer 70:185-191.
20. Helin, K. 1998. Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8:28-35.
21. Hennessy, K., and E. Kieff. 1983. One of two Epstein-Barr virus nuclear antigens contains a glycine-alanine copolymer domain. Proc. Natl. Acad. Sci. USA 80:5665-5669.
22. Johnson, D. J., K. Ohtani, and J. R. Nevins. 1994. Autoregulatory control of E2F1 expression in response to positive and negative regulators of cell cycle progression. Genes Dev. 8:1514-1525.
23. Jones, C. H., S. D. Hayward, and D. R. Rawlins. 1989. Interaction of lymphocyte-derived Epstein-Barr virus nuclear antigen (EBNA-1) with its DNA-binding sites. J. Virol. 63:101-110.
24. Kieff, E. 1996. Epstein-Barr Virus and its replication, p. 2343-2396. In B. N. Fields, D. M. Knipe, and P. M. Howley (ed.), Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
25. Lear, A. L., M. Rowe, M. G. Kurilla, S. Lee, S. Henderson, E. Kieff, and A. B. Rickinson. 1992. The Epstein-Barr virus (EBV) nuclear antigen 1 BamHI F promoter is activated on entry of EBV-transformed B cells into the lytic cycle. J. Virol. 66:7461-7468.
26. Levitskaya, J., A. Shapiro, A. Leonchiks, A. Ciechanover, and M. A. Masucci. 1997. Inhibition of ubiquitin/proteosome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc. Natl. Acad. Sci. USA 94:12616-12621.
27. Lew, D. J., V. Dulic, and S. I. Reed. 1991. Isolation of three novel human cyclins by rescue of G1 cyclin (Cln) function in yeast. Cell 66:1197-1206.
28. Liu, N., F. C. Lucibello, J. Zwicker, K. Engeland, and R. Muller. 1996. Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element. Nucleic Acids Res. 24:2905-2910.
29. Mann, G. J., E. A. Musgrove, R. M. Fox, and L. Thelander. 1988. Ribonucleotide reductase M1 subunit in cellular proliferation, quiescence, and differentiation. Cancer Res. 48:5151-5156.
30. Miyashita, E. M., B. Yang, G. J. Babcock, and D. A. Thorley-Lawson. 1997. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J. Virol. 71:4882-4891.
31. Miyashita, E. M., B. Yang, K. M. C. Lam, D. H. Crawford, and D. A. Thorley-Lawson. 1995. A novel form of Epstein-Barr virus latency in normal B cells in vivo. Cell 80:593-601.
32. Muller, R. 1995. Transcriptional regulation during the mammalian cell cycle. Trends Genet. 11:173-178.
33. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
34. Nevins, J. R., G. Leone, J. DeGregori, and L. Jakoi. 1997. Role of the Rb/E2F pathway in cell growth control. J. Cell. Physiol. 173:233-236.
35. Nonkwelo, C., E. B. Daniel Henson, and J. Sample. 1995. Characterization of the Epstein-Barr virus Fp promoter. Virology 206:183-195.
36. Nonkwelo, C., I. K. Rif, and J. Sample. 1997. The Epstein-Barr virus EBNA-1 promoter Qp requires an initiator-like element. J. Virol. 71:354-361.
37. Nonkwelo, C., I. K. Ruf, and J. Sample. 1997. Interferon-independent and -induced regulation of Epstein-Barr virus EBNA-1 gene transcription in Burkitt lymphoma. J. Virol. 71:6887-6897.
38. Nonkwelo, C., J. Skinner, A. Bell, A. Rickinson, and J. Sample. 1996. Transcription start sites downstream of the Epstein-Barr (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. J. Virol. 70:623-627.
39. Nonoyama, M., and J. S. Pagano. 1972. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus-producing cells. Nature 238:169-171.
40. Ohno, S., J. Luka, T. Lindahl, and G. Klein. 1977. Identification of a purified complement-fixing antigen as the Epstein-Barr-virus-determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proc. Natl. Acad. Sci USA 74:1605-1609.
41. Ohtani, K., J. DeGregori, G. Leone, D. R. Herendeen, T. J. Kelly, and J. R. Nevins. 1996. Expression of the HsOrc1 gene, a human ORC1 homolog, is regulated by cell proliferation via the E2F transcription factor. Mol. Cell. Biol. 16:6977-6984.
42. Ohtani, K., J. DeGregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene by transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146-12150.
43. Petti, L., C. Sample, and E. Kieff. 1990. Subnuclear localization and phosphorylation of Epstein-Barr virus latent infection nuclear proteins. Virology 176:563-574.
44. Pines, J., and T. Hunter. 1990. Human cyclin A is adenovirus E1A-associated protein p60 and behaves differently from cyclin B. Nature 346:760-763.
45. Pulvertaft, R. J. V. 1965. A study of malignant tumors in Nigeria by short-term tissue culture. J. Clin. Pathol. 18:261-271.
46. Rawlins, D. R., G. Milman, S. D. Hayward, and G. S. Hayward. 1985. Sequence-specific DNA binding of the Epstein-Barr virus nuclear antigen (EBNA-1) to clustered sites in the plasmid maintenance region. Cell 42:859-868.
47. Reedman, B. M., and G. Klein. 1973. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int. J. Cancer 11:499-520.
48. Sala, A., N. C. Nicolaides, A. Englehard, T. Bellon, D. C. Lawe, A. Arnold, X. Grana, A. Giordana, and B. Calabretta. 1994. Correlation between E2F-1 requirement in the S phase and E2F-1 transactivation of cell cycle-related genes in human cells. Cancer Res. 54:1402-1406.
49. Sample, J., L. Brooks, C. Sample, L. Young, M. Rowe, C. Gregory, A. Rickinson, and E. Kieff. 1991. Restricted Epstein-Barr virus protein expression in Burkitt lymphoma is due to a different Epstein-Barr nuclear antigen 1 transcriptional initiation site. Proc. Natl. Acad. Sci. USA 88:6343-6347.
50. Sample, J., E. B. Daniel Henson, and C. Sample. 1992. The Epstein-Barr virus nuclear protein 1 promoter active in type I latency is autoregulated. J. Virol. 66:4654-4661.
51. Schaefer, B. C., E. Paulson, J. L. Strominger, and S. H. Speck. 1997. Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency. Mol. Cell. Biol. 17:873-886.
52. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA-1 gene transcription in group I Burkitt's lymphoma cell lines. J. Virol. 69:5039-5047.
53. Schaefer, B. C., J. L. Strominger, and S. H. Speck. 1995. Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group 1 Burkitt lymphoma cell lines. Proc. Natl. Acad. Sci. USA 92:10565-10569.
54. Schaefer, B. C., M. Woisetschlaeger, J. L. Strominger, and S. H. Speck. 1991. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Proc. Natl. Acad. Sci. USA 88:6550-6554.
55. Schulze, A., K. Zerfass, D. Spitkovsky, S. Middendorp, J. Berges, K. Helin, P. Jansen-Durr, and B. Henglein. 1995. Cell cycle regulation of the cyclin A gene promoter is mediated by a variant E2F site. Proc. Natl. Acad. Sci. USA 92:11264-11268.
56. Sung, N. S., J. Wilson, M. Davenport, N. D. Sista, and J. S. Pagano. 1994. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Mol. Cell. Biol. 14:7144-7152.
57. Sung, N. S., J. Wilson, and J. S. Pagano. 1993. Characterization of cis-acting regulatory elements of the BamHI-F promoter of EBV, p. 239-242. In T. Tursz, J. S. Pagano, D. V. Ablashi, G. de The, G. Lenior, and G. R. Pearson (ed.). The Epstein-Barr virus and associated diseases. INSERM/John Libbey Eurotext Limited, London, United Kingdom.
58. Takada, K. 1984. Cross-linking of cell surface immunoglobulins induces Epstein-Barr virus in Burkitt's lymphoma lines. Int. J. Cancer 33:27-32.
59. Takada, K., K. Horinouchi, Y. Ono, T. Aya, M. Osato, M. Takahashi, and S. Hayasaka. 1991. An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNA. Virus Genes 5:147-156.
60. Tierney, R. J., N. Steven, L. S. Young, and A. B. Rickinson. 1994. Epstein-Barr virus latency in blood mononuclear cells: analysis of viral gene transcription during primary infection and in the carrier state. J. Virol. 68:7374-7385.
61. Tommasi, S., and G. P. Pfeifer. 1995. In vivo structure of the human cdc2 promoter: release of a p130-E2F-4 complex from sequences immediately upstream of the transcription initiation site coincides with induction of cdc2 expression. Mol. Cell. Biol. 15:6901-6913.
62. Trimarchi, J. M., B. Fairchild, K. Verona, K. Moberg, N. Andon, and J. A. Lees. 1998. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. USA 95:2850-2855.
63. Tsai, C.-H., S.-T. Lin, and Y.-S. Chang. 1995. Identification of a novel promoter located within the BamHI Q region of the Epstein-Barr virus genome for the EBNA-1 gene. DNA Cell Biol. 14:767-776.
64. Watanabe, N., J. Sakakibara, A. G. Hovanessian, T. Taniguchi, and T. Fujita. 1991. Activation of IFN-β element by IRF-1 requires a post-translational event in addition to IRF-1 synthesis. Nucleic Acids Res. 19:4421-4428.
65. Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323-330.
66. Wilson, G., and G. Miller. 1979. Recovery of Epstein-Barr virus from non-producer neonatal human lymphoid cell transformants. Virology 95:351-358.
67. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr virus genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81: 3806-3810.
68. Yates, J. L., and N. Guan. 1991. Epstein-Barr virus-derived plasmids replicate only once per cell cycle and are not amplified after entry into cells. J. Virol. 65:483-488.
69. Yates, J. L., N. Warren, and B. Sugden. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 821-815.
70. Zhang, D., L. Frappier, E. Gibbs, J. Hurwitz, and M. O'Donnel. 1998. Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein-Barr virus. Nucleic Acids Res. 26:631-637.
71. Zhang, L., and J. S. Pagano. 1997. IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol. Cell. Biol. 17:5748-5757.
72. Zwicker, J., N. Liu, K. Engeland, F. C. Lucibello, and R. Muller. 1996. Cell cycle regulation of E2F site occupation in vivo. Science 271:1595-1597.